drugset / Trial / NCT04953195

Thyroid Replacement Therapy in Patients With Subclinical Hypothyroidism

NCT04953195

Phase 4 Unknown 30 enrolled Beijing Chao Yang Hospital
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this experiment is to compared the changes of thyroid function, anti-thyroid peroxidase antibody, anti-thyroglobulin antibody, thyroid magnetic resonance T1-mapping and various metabolic indexes from baseline to the end of treatment (after the thyroid function had been normal for more than three months)

Timeline

Start
2019-01-01
Primary completion
2021-09-15
Completion
2021-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Levothyroxine Other / unclassified 50 ug

Indications